PREVALENCE AND PREDICTORS OF METABOLIC DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE IN A RETROSPECTIVE COHORT OF PATIENTS WITH ULCERATIVE COLITIS

被引：0
|
作者：
Elmoursi, Ahmed
Ali, Mohamed
Metawea, Ibrahim
Alareidi, Alaa
Abomhya, Ahmed
机构：
来源：
GASTROENTEROLOGY | 2024年 / 166卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S30 / S31
页数：2
相关论文
共 50 条
  • [41] Tailored Model of Care for Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease
    El-Kassas, Mohamed
    Awad, Abeer
    Elbadry, Mohamed
    Arab, Juan Pablo
    SEMINARS IN LIVER DISEASE, 2024, 44 (01) : 54 - 68
  • [42] Body composition differences in patients with Metabolic Dysfunction-Associated Steatotic Liver Disease
    Bernal-Contreras, Karen D.
    Berrospe-Alfaro, Montserrat
    de Cardenas-Rojo, Regina Lopez
    Ramos-Ostos, Martha H.
    Uribe, Misael
    Lopez-Mendez, Ivan
    Juarez-Hernandez, Eva
    FRONTIERS IN NUTRITION, 2024, 11
  • [43] Editorial: Evaluating the Prevalence of Metabolic Dysfunction-Associated Steatotic Liver Disease in Patients With Type 2 Diabetes and Hyperferritinemia
    Bhardwaj, Nakul J.
    Kim, Rebecca G.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2025, 61 (04) : 727 - 728
  • [44] Differential prevalence and prognostic value of metabolic syndrome components among metabolic-dysfunction associated steatotic liver disease (MASLD) patients
    Pustjens, Jesse
    van Kleef, Laurens
    Janssen, Harry L. A.
    de Knegt, Robert J.
    Brouwer, Willem Pieter
    JOURNAL OF HEPATOLOGY, 2024, 80 : S467 - S468
  • [45] Evaluation of liver fibrosis and steatohepatitis associated with metabolic dysfunction (MASH) in patients with inflammatory bowel disease (IBD) and steatotic liver disease associated with metabolic dysfunction (MASLD)
    Oliveira, E. C. S. D.
    Lopes, M. A.
    Beraldo, R. F.
    Castelhano, N. S.
    Baima, J. P.
    Herrerias, G. S. P.
    Quaglio, A. E., V
    Di Stasi, L. C.
    Barbosa, W. F.
    Silva, G. F.
    Sassaki, L. Y.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i666 - i666
  • [46] DISEASE PROGRESSION IN PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE USING PAIRED LIVER BIOPSY
    Turan, Dilara
    Ekelik, Merve M.
    Gumussoy, Mesut
    Kiremitci, Saba
    Bodakci, Emin
    Yilmaz, Volkan
    Guvenir, Tugce
    Duman, Serkan
    Ellik, Zeynep Melekolu
    Ozercan, Abdullah Mubin
    Er, Ramazan Erdem
    Karakaya, Fatih
    Sumer, Hale
    Elhan, Atilla H.
    Savas, Berna
    Toruner, Murat
    Idilman, Ramazan
    GASTROENTEROLOGY, 2024, 166 (05) : S1642 - S1642
  • [47] Prevalence and Impact of Protein-Calorie Malnutrition in Hospitalized Patients With Alcohol-Associated Liver Disease or Metabolic Dysfunction-Associated Steatotic Liver Disease
    Kim, Sowon
    Roney, Andrew
    Greb, Alexandra C.
    Limketkai, Berkeley
    Chen, Po-Hung
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S1413 - S1415
  • [48] PREDICTORS OF HEALTH-RELATED QUALITY OF LIFE IN METABOLIC DYSFUNCTION-STEATOTIC LIVER DISEASE IN A PROSPECTIVE COHORT
    Dalvi, Anushka
    Czapla, Blake
    Chen, Vincent L.
    GASTROENTEROLOGY, 2024, 166 (05) : S1635 - S1635
  • [49] From metabolic dysfunction-associated fatty liver disease to metabolic dysfunction-associated steatotic liver disease: Controversy and consensus
    Chen, Li
    WORLD JOURNAL OF HEPATOLOGY, 2023, 15 (12) : 1253 - 1257
  • [50] Psychosocial risks in metabolic dysfunction-associated steatotic liver disease
    Astrom, Hanne
    Takami Lageborn, Christine
    Hagstrom, Hannes
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2025, 19 (03) : 273 - 290
12345